These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3450147)

  • 1. [Effects of quercetin on the fluidity of platelet membrane lipids and platelet functions].
    Qin ZH; Shi L
    Yao Xue Xue Bao; 1987 Jul; 22(7):491-4. PubMed ID: 3450147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of nifedipine and anisodamine on platelet membrane fluidity and platelet aggregation in rats].
    Shao MG; Xu SH; Li CC; Xue QF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Oct; 9(5):381-5. PubMed ID: 2968865
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative aspects of omega-3 and omega-6 polyunsaturated fatty acids in rabbits and rats: effects on platelet function, thromboxane and prostacyclin generation, tissue phospholipid fatty acids and membrane fluidity.
    Bolton-Smith C; Gibney MJ; Vas Dias FW; Hillier K
    Br J Clin Pract Suppl; 1984; 31():37-41. PubMed ID: 6091719
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.
    Swies J; Robak J; Dabrowski L; Duniec Z; Michalska Z; Gryglewski RJ
    Pol J Pharmacol Pharm; 1984; 36(5):455-63. PubMed ID: 6442773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of sulphated flavonoids isolated from Flaveria bidentis on platelet aggregation.
    Guglielmone HA; Agnese AM; Núñez Montoya SC; Cabrera JL
    Thromb Res; 2005; 115(6):495-502. PubMed ID: 15792681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.
    Beretz A; Cazenave JP; Anton R
    Agents Actions; 1982 Jul; 12(3):382-7. PubMed ID: 6182778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 3,4-dihydroxyacetophenone on the membrane fluidity of platelets by fluorescence polarization analysis].
    Shi L; Qin ZH; Gao SX
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):149-51. PubMed ID: 2946154
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of quercetin on aggregation and intracellular free calcium of platelets.
    Xiao D; Gu ZL; Bai JP; Wang Z
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):223-6. PubMed ID: 7660815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats.
    Xiao D; Gu ZL; Qian ZN
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):505-8. PubMed ID: 8010047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lanosterol on platelet aggregation in human platelets.
    Hassall DG; Bruckdorfer KR; Sulpice JC; Lutton C
    Thromb Haemost; 1985 Dec; 54(4):760-3. PubMed ID: 4089810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of disodium quercetin-7,4'-disulfate on aggregation of pig platelets induced by thrombin and its mechanism.
    Liu W; Liang NC
    Acta Pharmacol Sin; 2000 Aug; 21(8):737-41. PubMed ID: 11501184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study of the inhibiting mechanism of anisodamine on rabbit platelets activated by E. coli endotoxin.
    Xu SH; Zhu GJ; Wu QX; Chen HC
    Chin Med J (Engl); 1989 Nov; 102(11):879-84. PubMed ID: 2517730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipids and platelet membrane fluidity in essential hypertension.
    Le Quan Sang KH; Mazeaud M; Astarie C; Duranthon V; Driss F; Devynck MA
    Thromb Haemost; 1993 Jan; 69(1):70-6. PubMed ID: 8383361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of membrane lipid composition, organization, and fluidity in human platelet function.
    Shattil SJ; Cooper RA
    Prog Hemost Thromb; 1978; 4():59-86. PubMed ID: 362482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of tetrapyrazine on membrane fluidity and electrophoretic mobility of platelets and the relation to its antiaggregation effect].
    Nie SQ; Xie ZC; Lin KC
    Yao Xue Xue Bao; 1985 Sep; 20(9):689-92. PubMed ID: 3834748
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet activation by platelet aggregation factor from Eisenia foelide.
    Qian R; Zhou YC; Zhuang QQ
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):432-5. PubMed ID: 7717070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism among flavonoids in inhibiting platelet aggregation and H2O2 production.
    Violi F; Pignatelli P; Pulcinelli FM
    Circulation; 2002 Feb; 105(8):e53. PubMed ID: 11864937
    [No Abstract]   [Full Text] [Related]  

  • 18. The interaction of flavonoids with mitochondria: effects on energetic processes.
    Dorta DJ; Pigoso AA; Mingatto FE; Rodrigues T; Prado IM; Helena AF; Uyemura SA; Santos AC; Curti C
    Chem Biol Interact; 2005 Apr; 152(2-3):67-78. PubMed ID: 15840381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation.
    Simon CG; Gear AR
    Biochemistry; 1998 Feb; 37(7):2059-69. PubMed ID: 9485333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The comparison in vitro the effects of pravastatin and quercetin on the selected structural parameters of membrane erythrocytes from patients with hypercholesterolemia].
    Broncel M; Franiak I; Koter-Michalak M; Duchnowicz P; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Feb; 22(128):112-6. PubMed ID: 17598654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.